IP Library › Granted Patent US 10,670,614
Granted Patent B2
US 10,670,614 · App. 16/514,304 · Granted Jun 2, 2020

Hemolysis detection device, system and method

Inventors: Andrew John Baxter (Sudbury, GB); Paul William Cotton (Halstead, GB)
Assignee: Siemens Healthcare Diagnostics Inc.
G01N33/721G01N33/491G01N33/4925G01N33/726A61M1/34G01N33/483G01N33/49G01N33/50G01N33/72G01N33/80G01N33/84G01N2015/055Y10T436/255
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,670,614
App. No.
16/514,304
Granted
Jun 2, 2020
Kind
B2
Abstract

Aspects of the present invention are directed to devices, systems and methods that enable the quick and reliable detection of hemolysis in a sample such that a sample which exhibits an unacceptable level of hemolysis can be flagged or disregarded in an associated diagnostic test.

Claims (9)

1. A device for determining an amount of hemoglobin in a plasma fraction wherein the device comprises:

a body with an upper portion and lower portion formed from a liquid impermeable material that is also inert to at least hemoglobin;

an opening defined in the upper portion of the body for introduction of a blood sample;

a plasma separation membrane disposed between the upper portion and the lower portion, the plasma separation membrane positioned to receive the blood sample from the opening;

a second membrane having a first portion positioned adjacent to and below the plasma separation membrane so as to receive a plasma fraction from the plasma separation membrane that was separated from the blood sample by the plasma separation membrane; and

a slit defined in the lower portion of the body and defining a pathway for energy to be applied to the second membrane, the slit overlapping a lower surface of the second membrane in a second portion of the second membrane that is not underneath the plasma separation membrane.

2. The device of claim 1 , wherein the plasma separation membrane comprises an asymmetric polysulfone material.

3. The device of claim 1 , wherein the second membrane is constructed of a porous or non-porous material that is inert to at least hemoglobin.

4. The device of claim 1 , wherein the second membrane is constructed of a cellulosic material, a glass fiber material, a porous polymeric material, or combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2019
From: BAXTER, ANDREW JOHN; COTTON, PAUL WILLIAM
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 049803/0500 →
Continuity (3)
Continuation 15513429
Provisional Application 62057452 · Sep 30, 2014
Related Publication 20190339293A1 · Nov 7, 2019